Table S1.
Parameter | WT (n = 11) | β-arrestin 1 KO (n = 4) | β-arrestin 2 KO (n = 6) | AT1R KO (n = 13) |
Compliance parameters | ||||
EDPVR (linear) slope | 0.26 ± 0.05 | 0.17 ± 0.01 | 0.21 ± 0.02 | 0.35 ± 0.04 |
EDPVR (linear) intercept | −3.06 ± 1.34 | −1.46 ± 1.72 | −2.45 ± 1.26 | −7.74 ± 2.67 |
EDPVR (quadratic) β coefficient | 0.083 ± 0.015 | 0.038 ± 0.010 | 0.115 ± 0.041 | 0.047 ± 0.008 |
EDPVR (quadratic) α coefficient | 1.164 ± 0.445 | 1.974 ± 0.992 | 1.070 ± 0.563 | 1.260 ± 0.554 |
Contractility parameters | ||||
ESPVR (linear) slope | 4.02 ± 0.68 | 3.19 ± 0.29 | 3.48 ± 0.91 | 2.68 ± 0.26 |
ESPVR (linear) intercept | −4.53 ± 7.39 | −6.60 ± 7.59 | −7.19 ± 10.55 | −12.12 ± 6.71 |
ESPVR (quadratic) a | −1.82 ± 1.14 | −0.61 ± 0.25 | −0.34 ± 0.12 | −0.04 ± 0.01* |
ESPVR (quadratic) V0 | 9.85 ± 5.80 | 4.70 ± 7.00 | 9.47 ± 4.95 | −0.90 ± 5.68 |
ESPVR (quadratic) E′max | 16.09 ± 3.84 | 11.59 ± 2.24 | 9.93 ± 1.93 | 5.02 ± 0.55* |
PRSW slope | 59.69 ± 4.11 | 59.26 ± 4.91 | 42.63 ± 7.86 | 44.46 ± 4.83 |
PRSW intercept | 8.10 ± 6.94 | 9.88 ± 4.53 | 1.87 ± 8.70 | −0.92 ± 3.68 |
dP/dtmax vs. EDV slope | 154.50 ± 22.74 | 103.50 ± 9.78 | 88.09 ± 10.21 | 113.40 ± 17.71 |
dP/dtmax vs. EDV intercept | −14.59 ± 8.39 | −19.63 ± 5.16 | −32.39 ± 11.67 | −30.26 ± 13.79 |
Emax | 7.79 ± 1.29 | 8.29 ± 1.11 | 6.44 ± 1.41 | 4.80 ± 0.47 |
Average load-independent parameters obtained by inferior vena cava constriction performed on a separate cohort of WT (n = 11), β-arrestin 1 KO (n = 4), β-arrestin 2 KO (n = 6), and AT1R KO (n = 7) mice. Parameters of LV compliance (linear- and quadratic-derived EDPVR) and LV contractility (linear- and quadratic-derived ESPVR, PRSW, dP/dtmax vs. EDV and Emax) are listed separately for each genotype. Errors reflect SEM. ESPVR, end-systolic PV relationship; a, coefficient of curvilinearity; Vo, volume intercept; E′max, maximum slope of quadratic ESPVR; PRSW, preload recruitable stroke work; Emax, maximal elastance.
P < 0.05 vs. WT, one-way ANOVA with Bonferroni’s multiple comparison test.